Medtronic Invests $700M in Cornerstone Robotics to Expand Robotic Surgery Portfolio
MDT sits 26% above its 52-week low of $73.31.
Summary
Medtronic is investing approximately $700 million in Cornerstone Robotics, gaining distribution rights to the Sentire surgical system in select markets outside the U.S. The deal adds a second robotic platform to complement Medtronic's Hugo system, creating a two-platform portfolio aimed at expanding global access to robotic-assisted surgery. Sentire has CE Mark approval and market clearance in China and Singapore, while Hugo is used in over 35 countries. This follows Medtronic's recent FDA 510(k) submissions to expand Hugo indications and its strategic investments in Beluga Medical and CardioACC. The partnership strengthens Medtronic's position in the fast-growing robotic surgery market, where adoption remains in single digits globally.
At the time of this announcement, MDT was trading at $92.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $116B. The 52-week trading range was $73.31 to $106.33. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.